Multiple myeloma (MM)
Clinical trials for Multiple myeloma (MM) explained in plain language.
Never miss a new study
Get alerted when new Multiple myeloma (MM) trials appear
Sign up with your email to follow new studies for Multiple myeloma (MM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cell therapy targets a marker on myeloma cells
Cure Stopped earlyResearchers are testing a cell therapy called OPC-415 in adults with multiple myeloma that has come back or stopped responding to standard treatments. Participants must have the MMG49 antigen on their cancer cells and have already tried at least two prior regimens. The trial meas…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase 1/2 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
New multiple myeloma drug trial halted early
Disease control Stopped earlyThis early-stage study tested a new drug called WVT078, alone or with another drug (WHG626), in 56 people with multiple myeloma that returned or didn't respond to at least two prior treatments. The main goal was to find a safe dose and check for side effects. The study was termin…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Experimental combo for tough blood cancers hits early snag
Disease control Stopped earlyThis early-stage trial tested a combination of two experimental drugs, VOB560 and MIK665, in 37 people with relapsed or refractory non-Hodgkin lymphoma, acute myeloid leukemia, or multiple myeloma. The drugs aim to block proteins that help cancer cells survive, forcing them to di…
Matched conditions: MULTIPLE MYELOMA (MM)
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC